Showing 2631-2640 of 10544 results for "".
Employee Engagement
https://practicaldermatology.com/topics/practice-management/employee-engagement/21267/Promoting employee engagement is key to success in the workplace.Upadacitinib and Cardiovascular Events in AD
https://practicaldermatology.com/issues/october-2025/upadacitinib-and-cardiovascular-events-in-ad/39755/A recent review examined whether upadacitinib, a selective Janus kinase 1 (JAK1) inhibitor approved for atopic dermatitis (AD) and other chronic inflammatory diseases, may—despite a boxed warning to the contrary—confer cardioprotective and thromboprotective effects.Visible Benefit of Compression for Leukocytoclastic Vasculitis
https://practicaldermatology.com/programs/practical-dermatology/visible-benefit-of-compression-for-leukocytoclastic-vasculitis/24212/The use of compression stockings has been suggested in the management of leukocytoclastic vasculitis (LCV), however there are a lack of studies in the literature that provide evidence of the benefit of compression therapy in the treatment of LCV.1,2 Here we present a case that visually demonstratesTherapies in Practice: New Options for Ichthyosis Vulgaris
https://practicaldermatology.com/topics/general-topics/therapies-in-practice-new-options-for-ichthyosis-vulgaris/21933/Emerging data confirm that atopic dermatitis and ichthyosis share pathogenic traits, suggesting a role for barrier repair formulations in management.Dermatoscopy: Chaos and Clues
https://practicaldermatology.com/topics/general-topics/dermatoscopy-chaos-and-clues/21345/A decision algorithm for pigmented skin lesions.Comorbidities in Atopic Dermatitis
https://practicaldermatology.com/issues/october-2025/comorbidities-in-atopic-dermatitis/39756/In this article, as part of a series on comorbidities associated with immune-mediated skin diseases, we explore the spectrum of comorbidities linked to AD.Emrosi Launched in the US for Rosacea
https://practicaldermatology.com/series/dermwire-tv/emrosi-launched-in-the-us-for-rosacea/33943/In this week's DermwireTV, a new treatment for rosacea is launched in the US; long-term data is presented for tapinarof 1% cream for atopic dermatitis; and in our C-Suite Chats segment, we speak with the CEO and Co-Founder of Mama Sol.In The Pipeline: Phase 1, 2, and 3
https://practicaldermatology.com/programs/practical-dermatology-focus-psoriasis/pipeline-phase-1-2-and-3/29087/This summary provides the latest news on of some of the recent Phase 1, Phase 2, and Phase 3 clinical studies for psoriasis treatments.Rosacea Unveiled: A YoungMD Connect Open Discussion with Dr. Corey Hartman
https://practicaldermatology.com/youngmd-connect/wrap-ups/rosacea-unveiled-a-youngmd-connect-open-discussion-with-dr-corey-hartman/27168/In his YoungMD Connect virtual session on the topic of rosacea, Dr. Corey Hartman shared extensive experience with the eager viewing audience. Topics discussed included treating patients with rosacea, including those with skin of color, as well as clinical pearls on diagnosing and managing this commOrganic vs. Paid Marketing: What Is the Difference and Which Is Better for Your Dermatology Practice?
https://practicaldermatology.com/topics/practice-management/organic-vs-paid-marketing-what-is-the-difference-and-which-is-better-for-your-dermatology-practice/23877/Advertising and marketing, organic and paid, inbound and outbound—which better serve your practice?